{{Rsnum
|rsid=4522809
|Gene=TGFBR2
|Chromosome=3
|position=30627192
|Orientation=minus
|GMAF=0.4238
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TGFBR2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 26.5 | 42.5 | 31.0
| HCB | 5.8 | 40.9 | 53.3
| JPT | 8.8 | 42.5 | 48.7
| YRI | 17.8 | 47.9 | 34.2
| ASW | 29.8 | 45.6 | 24.6
| CHB | 5.8 | 40.9 | 53.3
| CHD | 4.6 | 39.4 | 56.0
| GIH | 31.7 | 51.5 | 16.8
| LWK | 21.8 | 58.2 | 20.0
| MEX | 24.1 | 39.7 | 36.2
| MKK | 16.0 | 51.3 | 32.7
| TSI | 22.5 | 47.1 | 30.4
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19601999
|Title=A genetic polymorphism in transforming growth factor beta receptor-2 is associated with serum osteopontin
}}

{{PMID Auto
|PMID=19672284
|Title=Association of the TGF-beta receptor genes with abdominal aortic aneurysm
|OA=1
}}

{{PMID Auto
|PMID=19048631
|Title=Oral facial clefts and gene polymorphisms in metabolism of folate/one-carbon and vitamin A: a pathway-wide association study.
|OA=1
}}

{{PMID Auto
|PMID=21527583
|Title=TGF-beta signaling pathway and breast cancer susceptibility.
|OA=1
}}

{{PMID Auto
|PMID=22431140
|Title=TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}